Related references
Note: Only part of the references are listed.The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
Theresa E. Hickey et al.
NATURE MEDICINE (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing
Timour Baslan et al.
ELIFE (2020)
Biomarker function of HMGA2 in ultraviolet-induced skin cancer development
Wootae Ha et al.
EXPERIMENTAL DERMATOLOGY (2020)
Epigenetic Therapies for Cancer
Susan E. Bates
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hairless regulates p53 target genes to exert tumor suppressive functions in glioblastoma
Lemlem Brook et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC
Hung-Jung Wang et al.
ONCOGENE (2019)
LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression
Xin Hu et al.
ONCOGENE (2019)
Clinical epigenetics: seizing opportunities for translation
Maria Berdasco et al.
NATURE REVIEWS GENETICS (2019)
SMYD3 promotes the epithelial-mesenchymal transition in breast cancer
Claudio Fenizia et al.
NUCLEIC ACIDS RESEARCH (2019)
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Yuan Fang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells
Yue-peng Cao et al.
ACTA PHARMACOLOGICA SINICA (2019)
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer
Rosaria Benedetti et al.
CANCERS (2019)
The timeline of epigenetic drug discovery: from reality to dreams
A. Ganesan et al.
CLINICAL EPIGENETICS (2019)
SETDB1 regulates SMAD7 expression for breast cancer metastasis
Tae Young Ryu et al.
BMB REPORTS (2019)
Epigenetic therapy in immune-oncology
Peter A. Jones et al.
NATURE REVIEWS CANCER (2019)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Vitamin D receptor expression in invasive breast tumors and breast cancer survival
Linnea Huss et al.
BREAST CANCER RESEARCH (2019)
Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other Cancers
Anas Maatough et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy
Guan-Jun Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Eytan M. Stein et al.
BLOOD (2018)
KDM6B Counteracts EZH2-Mediated Suppression of IGFBP5 to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast Cancer
Wenyu Wang et al.
MOLECULAR CANCER THERAPEUTICS (2018)
KDM4B-regulated unfolded protein response as a therapeutic vulnerability in PTEN-deficient breast cancer
Wenyu Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression
S. P. Rowbotham et al.
NATURE COMMUNICATIONS (2018)
Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
Eleanor E. R. Harris
INTERNATIONAL JOURNAL OF BREAST CANCER (2018)
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Roisin M. Connolly et al.
CLINICAL CANCER RESEARCH (2017)
The Mammalian Hairless Protein as a DNA Binding Phosphoprotein
Lemlem Brook et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome
Yuna Kim et al.
NATURE MEDICINE (2017)
Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression
C. Cao et al.
ONCOGENE (2017)
In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
Basel Abu-Jamous et al.
MOLECULAR CANCER (2017)
Arginine Methylation: The Coming of Age
Romeo S. Blanc et al.
MOLECULAR CELL (2017)
New insights into the epigenetics of inflammatory rheumatic diseases
Esteban Ballestar et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
Molecular heterogeneity in breast cancer: State of the science and implications for patient care
Rachel E. Ellsworth et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin
Ya-fang Wang et al.
NATURE COMMUNICATIONS (2017)
Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression
Lin Chen et al.
ONCOTARGET (2017)
JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity
Jing Xun et al.
ONCOTARGET (2017)
Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
Roberta Mazzone et al.
CLINICAL EPIGENETICS (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer
J-Y Chen et al.
ONCOGENESIS (2017)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
Targeting Histone Methylation in Cancer
Michael T. McCabe et al.
CANCER JOURNAL (2017)
Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer
Wei Mo et al.
CLINICAL CANCER RESEARCH (2016)
Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer
Guanglong Jiang et al.
BMC GENOMICS (2016)
Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism
Yanyan Cai et al.
CANCER CELL (2016)
MiR-502/SET8 regulatory circuit in pathobiology of breast cancer
Ben Liu et al.
CANCER LETTERS (2016)
Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
Ewa M. Michalak et al.
MOLECULAR ONCOLOGY (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Andrew P. Feinberg et al.
NATURE REVIEWS GENETICS (2016)
Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis
M. F. Montenegro et al.
ONCOGENE (2016)
Chemically induced skin carcinogenesis: Updates in experimental models (Review)
Monica Neagu et al.
ONCOLOGY REPORTS (2016)
The Emerging Role of Epigenetics in Inflammation and Immunometabolism
Sukanya Raghuraman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer
Jane Borley et al.
ANNALS OF MEDICINE (2015)
Dysfunction of the Reciprocal Feedback Loop between GATA3-and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis
Wenzhe Si et al.
CANCER CELL (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
TP53: an oncogene in disguise
T. Soussi et al.
CELL DEATH AND DIFFERENTIATION (2015)
SET7/9 regulates cancer cell proliferation by influencing β-catenin stability
Changchun Shen et al.
FASEB JOURNAL (2015)
Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer
S. Stolzenburg et al.
ONCOGENE (2015)
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
Min-Hyung Cho et al.
NATURE COMMUNICATIONS (2015)
Prolonged Ezh2 Depletion in Glioblastoma Causes a Robust Switch in Cell Fate Resulting in Tumor Progression
Nienke A. de Vries et al.
CELL REPORTS (2015)
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications
Katarzyna J. Jerzak et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Selective Inhibitors of Protein Methyltransferases
H. Uemit Kaniskan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer
Mark A. Wade et al.
NUCLEIC ACIDS RESEARCH (2015)
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer
Lanxin Liu et al.
ONCOTARGET (2015)
High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer
E. A. Reijm et al.
ANNALS OF ONCOLOGY (2014)
NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
Filippos Kottakis et al.
CANCER RESEARCH (2014)
UTX and MLL4 Coordinately Regulate Transcriptional Programs for Cell Proliferation and Invasiveness in Breast Cancer Cells
Jae-Hwan Kim et al.
CANCER RESEARCH (2014)
EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation
William D. Bradley et al.
CHEMISTRY & BIOLOGY (2014)
A Chemical Tool for In Vitro and In Vivo Precipitation of Lysine Methyltransferase G9a
Kyle D. Konze et al.
CHEMMEDCHEM (2014)
Hairless is a histone H3K9 demethylase
Liang Liu et al.
FASEB JOURNAL (2014)
H3K9 histone methyltransferase G9a-mediated transcriptional activation of p21
Si-Taek Oh et al.
FEBS LETTERS (2014)
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities
Dante Rotili et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Minireview: Conversing With Chromatin: The Language of Nuclear Receptors
Simon C. Biddie et al.
MOLECULAR ENDOCRINOLOGY (2014)
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
Ramzi F. Sweis et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
Li-Liang Li et al.
BREAST CANCER RESEARCH (2014)
Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer
Prem Khanal et al.
FASEB JOURNAL (2013)
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP
Feng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Towards Sustained Silencing of HER2/neu in Cancer By Epigenetic Editing
Fahimeh Falahi et al.
MOLECULAR CANCER RESEARCH (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
Matthew J. Ellis et al.
CANCER DISCOVERY (2013)
Exomic Sequencing of Four Rare Central Nervous System Tumor Types
Chetan Bettegowda et al.
ONCOTARGET (2013)
Hereditary Breast Cancer: The Era of New Susceptibility Genes
Paraskevi Apostolou et al.
BIOMED RESEARCH INTERNATIONAL (2013)
A Small-Molecule Probe of the Histone Methyltransferase G9a Induces Cellular Senescence in Pancreatic Adenocarcinoma
Yuan Yuan et al.
ACS CHEMICAL BIOLOGY (2012)
Hairless Modulates Ligand-Dependent Activation of the Vitamin D Receptor-Retinoid X Receptor Heterodimer
Masayuki Chuma et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Prdm3 and Prdm16 are H3K9me1 Methyltransferases Required for Mammalian Heterochromatin Integrity
Ines Pinheiro et al.
CELL (2012)
G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer
Chenfang Dong et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer
Nina Ditsch et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Negative Regulation of JAK2 by H3K9 Methyltransferase G9a in Leukemia
Hye-Ju Son et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
Perceiving the epigenetic landscape through histone readers
Catherine A. Musselman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Loss of Hairless Confers Susceptibility to UVB-Induced Tumorigenesis via Disruption of NF-kappaB Signaling
Hyunmi Kim et al.
PLOS ONE (2012)
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
Weibo Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Chromatin landscape and endocrine response in breast cancer
Luca Magnani et al.
EPIGENOMICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Notes From the Field: Fatal Fungal Soft-Tissue Infections After a Tornado—Joplin, Missouri, 2011
ANNALS OF EMERGENCY MEDICINE (2011)
H3K9 methyltransferase G9a and the related molecule GLP
Yoichi Shinkai et al.
GENES & DEVELOPMENT (2011)
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
Masoud Vedadi et al.
NATURE CHEMICAL BIOLOGY (2011)
Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases
Nima Mosammaparast et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1
Christian Magerl et al.
HUMAN PATHOLOGY (2010)
G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53
Jing Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704
Ananya Manuyakorn et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.
Feng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases
Yanqi Chang et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Pygo2 Associates with MLL2 Histone Methyltransferase and GCN5 Histone Acetyltransferase Complexes To Augment Wnt Target Gene Expression and Breast Cancer Stem-Like Cell Expansion
Jiakun Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Immune Competency of a Hairless Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice
Beverly S. Schaffer et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases
John R. Horton et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation
Datsun A. Hsia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Histone methyltransferases in cancer
Mareike Albert et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Histone demethylases in development and disease
Marianne Terndrup Pedersen et al.
TRENDS IN CELL BIOLOGY (2010)
Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers
Ping Chi et al.
NATURE REVIEWS CANCER (2010)
Global Levels of Histone Modifications Predict Prognosis in Different Cancers
David B. Seligson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
Somaia E. Elsheikh et al.
CANCER RESEARCH (2009)
LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
Yan Wang et al.
CELL (2009)
The HP1α-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin
Alejandra Loyola et al.
EMBO REPORTS (2009)
The hairless mouse in skin research
Fernando Benavides et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a
Feng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
Yanqi Chang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
Paul A. C. Cloos et al.
GENES & DEVELOPMENT (2008)
Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis
Yuki Okada et al.
NATURE (2007)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
The mammalian epigenome
Bradley E. Bernstein et al.
CELL (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase
Stefan Kubicek et al.
MOLECULAR CELL (2007)
5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3K9 di-methylation levels are linked to tumor suppressor gene reactivation
R. J. Wozniak et al.
ONCOGENE (2007)
Profile of histone lysine methylation across transcribed mammalian chromatin
Christopher R. Vakoc et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3
Paul A. C. Cloos et al.
NATURE (2006)
The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36
Robert J. Klose et al.
NATURE (2006)
JHDM2A, a JmjC-containing H3K9 dernethylase, facilitates transcription activation by androgen receptor
Kenichi Yamane et al.
CELL (2006)
Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins
VP Tryndyak et al.
CANCER BIOLOGY & THERAPY (2006)
JmjC-domain-containing proteins and histone demethylation
Robert J. Klose et al.
NATURE REVIEWS GENETICS (2006)
Hairless triggers reactivation of hair growth by promoting Wnt signaling
GMJ Beaudoin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
D Greiner et al.
NATURE CHEMICAL BIOLOGY (2005)
Global histone modification patterns predict risk of prostate cancer recurrence
DB Seligson et al.
NATURE (2005)
The co-repressor hairless has a role in epithelial cell differentiation in the skin
JM Zarach et al.
DEVELOPMENT (2004)
The thyroid hormone-regulated compressor hairless associates with histone deacetylases in neonatal rat brain
GB Potter et al.
MOLECULAR ENDOCRINOLOGY (2002)
G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis
M Tachibana et al.
GENES & DEVELOPMENT (2002)
Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer
M Friedrich et al.
HISTOCHEMICAL JOURNAL (2002)
The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor
GB Potter et al.
GENES & DEVELOPMENT (2001)
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
AJ Bannister et al.
NATURE (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Molecular evolution of the GATA family of transcription factors: Conservation within the DNA-binding domain
JA Lowry et al.
JOURNAL OF MOLECULAR EVOLUTION (2000)
Share Paper
